COVID-19, vaccines and deficiency of ACE2 and other angiotensinases. Closing the loop on the "Spike effect"-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

COVID-19, vaccines and deficiency of ACE2 and other angiotensinases. Closing the loop on the "Spike effect"

Published:2022-09 Issue: Volume:103 Page:23-28
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Angeli Fabio^ORCID,Reboldi Gianpaolo^ORCID,Trapasso Monica,Zappa Martina^ORCID,Spanevello Antonio,Verdecchia Paolo^ORCID

Publisher

Elsevier BV

Subject

Internal Medicine

Reference94 articles.

1. COVID-19: ACE2 centric infective disease?;Verdecchia;Hypertension,2020

2. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection;Verdecchia;Eur J Intern Med,2020

3. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: one year later;Angeli;Eur J Intern Med,2021

4. SARS-CoV-2 infection and ACE2 inhibition;Angeli;J Hypertens,2021

5. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China;Wu;JAMA Intern Med,2020

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A retrospective prognostic evaluation using unsupervised learning in the treatment of COVID-19 patients with hypertension treated with ACEI/ARB drugs;PeerJ;2024-05-13

2. Innate and adaptative immune mechanisms of COVID-19 vaccines. Serious adverse events associated with SARS-CoV-2 vaccination: A systematic review;Vacunas (English Edition);2024-04

3. Mecanismos inmunitarios innatos y adaptativos de las vacunas COVID-19. Efectos adversos graves asociados a la vacunación contra el SARS-CoV-2: una revisión sistemática;Vacunas;2024-04

4. Immunogenicity and Safety of Half-Dose Heterologous mRNA-1273 Booster Vaccination for Adults Primed with the CoronaVac® and ChAdOx1-S Vaccines for SARS-CoV-2;Vaccines;2024-03-22

5. Glycyrrhizic acid restores the downregulated hepatic ACE2 signaling in the attenuation of mouse steatohepatitis;European Journal of Pharmacology;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3